Oxidative stress, cell cycle, and neurodegeneration

Journal of Clinical Investigation

Volumn 111, Issue 6, 2003, Pages 785-793

  Klein, Jeffrey A ^a   Ackerman, Susan L ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE; CELL DEATH; NERVE CELL; NERVE CELL DEGENERATION; NERVE DEGENERATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; ANIMAL; DEGENERATIVE DISEASE; HUMAN; METABOLISM; PHYSIOLOGY;

REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANIMALS; CELL CYCLE; CELL DEATH; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 0037366104     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200318182     Document Type: Review

References (86)

1. Nagy, Z., Esiri, M.M., and Smith, A.D. 1998. The cell division cycle and the pathophysiology of Alzheimer's disease. Neuroscience. 87:731-739.
2. Nagy, Z. 1999. Mechanisms of neuronal death in Down's syndrome. J. Neural Transm. Suppl. 57:233-245.
3. Herrup, K., and Busser, J.C. 1995. The induction of multiple cell cycle events precedes target-related neuronal death. Development. 121:2385-2395.
4. Migheli, A., et al. 1999. A cell cycle alteration precedes apoprosis of granule cell precursors in the weaver mouse cerebellum. Am. J. Pathol. 155:365-373.
5. Klein, J.A., et al. 2002. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature. 419:367-374.
6. Kannan, K., and Jain, S.K. 2000. Oxidative stress and apoptosis. Pathophysiology. 7:153-163.
7. Leonatdi, E.T., and Mytilineou, C. 1998. Cell culture models of neuronal degeneration and neuroprotection. Implications for Parkinson's disease. Adv. Exp. Med. Biol. 446:203-222.
8. Yokota, T., et al. 2001. Delayed-onset ataxia in mice lacking alpha-tocopherol transfer protein: model for neutonal degeneration caused by chronic oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 98:15185-15190.
9. Melov, S., et al. 1998. A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nat. Genet. 18:159-163.
10. Sayte, L.M., Smith, M.A., and Perry, G. 2001. Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8:721-738.
11. Aksenov, M.Y., et al. 1998. The expression of key oxidative stress-handling genes in different brain regions in Alzheimet's disease. J. Mol. Neurosci. 11:151-164.
12. Hensley, K., et al. 1994. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 91:3270-3274.
13. Jang, J.H., and Surh, Y.J. 2002. Beta-amyloid induces oxidative DNA damage and cell death through activation of c-Jun N terminal kinase. Ann. N. Y. Acad. Sci. 973:228-236.
14. Matsuoka, Y., Picciano, M., La Francois, J., and Duff, K. 2001. Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease. Neuroscience. 104:609-613.
15. Smith, M.A., Rottkamp, C.A., Nunomura, A., Raina, A.K., and Perry, G. 2000. Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta. 1502:139-144.
16. Jenner, P., and Olanow, C.W. 1996. Oxidative stress and the pathogenesis of Parkinson's disease. Neurology. 47(Suppl. 3):S161-S170.
17. Giasson, B.I., Ischiropoulos, H., Lee, V.M., and Trojanowski, J.Q. 2002. The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. Free Radic. Biol. Med. 32:1264-1275.
18. Fukushima, T., et al. 1995. Radical formation site of cerebral complex I and Parkinson's disease. J. Neurosci. Res. 42:385-390.
19. Cassarino, D.S., et al. 1997. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim. Biophys. Acta. 1362:77-86.
20. Sherer, T.B., et al. 2002. An in vitro model of Parkinson's disease: linking mitochondrial impairment to altered alpha-synuclein metabolism and oxidative damage. J. Neurosci. 22:7006-7015.
21. Chun, H.S., et al. 2001. Dopaminergic cell death induced by MPP(+), oxidant and specific neurotoxicants shares the common molecular mechanism. J. Neurochem. 76:1010-1021.
22. Albers, D.S., and Augood, S.J. 2001. New insights into progressive supranuclear palsy. Trends Neurosci. 24:347-353.
23. Butterfield, D.A., and Kanski, J. 2001. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech. Ageing Dev. 122:945-962.
24. Kim, J.L., et al. 2001. Oxidative stress and neurodegeneration in prion diseases. Ann. N. Y. Acad. Sci. 928:182-186.
25. Cassarino, D.S., and Bennett, J.P., Jr. 1999. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration. Brain Res. Brain Res. Rev. 29:1-25.
26. Heintz, N. 1993. Cell death and the cell cycle: a relationship between transformation and neurodegeneration? Trends Biochem. Sci. 18:157-159.
27. Feddersen, R.M., Ehlenfeldt, R., Yunis, W.S., Clark, H.B., and Orr, H.T. 1992. Disrupted cerebellar cortical development and progressive degeneration of Purkinje cells in SV40 T antigen transgenic mice. Neuron. 9:955-966.
28. Frade, J.M. 2000. Unscheduled re-entry into the cell cycle induced by NGF precedes cell death in nascent retinal neurones. J. Cell Sci. 113:1139-1148.
29. Verdaguer, E., et al. 2002. Kainic acid-induced apoptosis in cerebellar granule neurons: an attempt at cell cycle re-entry. Neuroreport. 13:413-416.
30. Copani, A., et al. 1999. Mitotic signaling by beta-amyloid causes neuronal death. FASEB J. 13:2225-2234.
31. Copani, A., et al. 2002. Beta-amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neurons. J. Neurosci. 22:3963-3968.
32. Feddersen, R.M., Clark, H.B., Yunis, W.S., and Orr, H.T. 1995. In vivo viability of postmitolic Purkinje neurons requires pRb family member function. Mol. Cell. Neurosci. 6:153-167.
33. Al-Ubaidi, M.R., et al. 1997. Unscheduled DNA replication precedes apoptosis of photoreceptors expressing SV40 T antigen. Exp. Eye Res. 64:573-585.
34. ElShamy, W.M., Fridvall, L.K., and Ernfors, P. 1998. Growth arrest failure, G1 restriction point overtide, and S phase death of sensory precursor cells in the absence of neurotrophin-3. Neuron. 21:1003-1015.
35. Katchanov, J., et al. 2001. Mild cerebral ischemia reduces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death. J. Neurosci. 21:5045-5053.
36. Osuga, H., et al. 2000. Cyclin-dependent kinases as a therapeutic target for stroke. Proc. Natl. Acad. Sci. U. S. A. 97:10254-10259.
37. Rangathan, S., and Bowser, R. 2003. Alterations in G(1) to S phase cell-cycle regulators during amyotrophic lateral scletosis. Am. J. Pathol. 162:823-835.
38. McShea, A., Harris, P.L., Webster, K.R., Wahl, A.F., and Smith, M.A. 1997. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am. J. Pathol. 150:1933-1939
39. Busser, J., Geldmacher, D.S., and Herrup, K. 1998. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J. Neurosci. 18:2801-2807.
40. Hertup, K., and Arendt, T. 2002. Re-expression of cell cycle proteins induces neutonal cell death during Alzheimer's disease. J. Alzheimers Dis. 4:243-247.
41. Yang, Y., Geldmacher, D.S., and Herrup, K. 2001 DNA replication precedes neuronal cell death in Alzheimer's disease. J. Neurosci. 21:2661-2668.
42. Nagy, Z., Esiri, M.M., and Smith, A.D. 1997. Expression of cell division markets in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol. (Berl.) 93:294-300.
43. Konishi, Y., Lehtinen, M., Donovan, N., and Bonni, A. 2002. Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol. Cell. 9:1000-1016.
44. Migliore, L., and Coppede, F. 2002. Genetic and environmental factors in cancer and neurodegenerative diseases. Mutat. Res. 512:135-153.
45. Chen, Q.M., Liu, J., and Merrett, J.B. 2000. Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts. Biochem. J. 347:543-551.
46. Barber, B.R. 1971. Research news. Mouse News Leiter. 45:34-35.
47. Bronson, R.T., Lane, P.W., Harris, B.S., and Davisson, M.T. 1990. Harlequin (Hq) produces progressive cerebellar atrophy. Mouse Genome. 87:110.
48. Susin, S.A., et al. 1999. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:441-446.
49. Mate, M.J., et al. 2002. The crystal structure of the mouse apoptosis-inducing factor AIF. Nat. Struct. Biol. 9:442-446.
50. Cande, C., Cecconi, F., Dessen, P., and Kroemer, G. 2002. Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J. Cell Sci. 115:4727-4734.
51. Miramar, M.D., et al. 2001. NADH oxidase activity of mitochondrial apoptosis-inducing factor. J. Biol. Chem. 276:16391-16398.
52. Wang, X., Yang, C., Chai, J., Shi, Y., and Xue, D. 2002. Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science. 298:1587-1592,
53. Arnoult, D., et al. 2002. Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoprotic stimuli. J. Cell Biol. 159:923-929.
54. Joza, N., et al. 2001. Essential role of the mitochondrial apoprosis-inducing factor in programmed cell death. Nature. 410:549-554.
55. Bonni, A. 2003. Neurodegeneration: a non-apoptotic role for AIF in the brain. Curr. Biol. 13:R19-R21.
56. Lipton, S.A., and Bossy-Wetzel, E. 2002. Dueling activities of AIF in cell death versus survival: DNA binding and redox activity. Cell. 111:147-150.
57. Holmgren, A. 2000. Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid. Redox Signal. 2:811-820.
58. White, A.R., et al. 1998. Survival of cultured neurons from amyloid precursor protein knock-out mice against Alzheimer's amyloid-beta toxicity and oxidative stress. J. Neurosci. 18:6207-6217.
59. Turker, M.S. 2000. Somatic cell mutations: can they provide a link between aging and cancer? Mech. Ageing Dev. 117:1-19.
60. Halliwell, B. 1998. Can oxidative DNA damage be used as a biomarker ofcancer risk in humans? Problems, resolutions and preliminary results from nutritional supplementation studies. Free Radic. Res. 29:469-486.
61. Sekiguchi, M., and Tsuzuki, T. 2002. Oxidative nucleotide damage: consequences and prevention. Oncogene. 21:8895-8904.
62. Dolle, M.E., et al. 1997. Rapid accumulation of genome rearrangements in liver but not in brain of old mice. Nat. Genet. 17:431-434.
63. Pazin, M.J., and Kadonaga, J.T. 1997. What's up and down with histone deacetylation and transcription? Cell. 89:325-328.
64. Boutillier, A.L., Trinh, E., and Loeffler, J.P. 2003. Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis. J. Neurochem. 84:814-828.
65. Nahle, Z., et al. 2002. Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 4:859-864.
66. Rahman, I. 2002. Oxidative stress, transcription factors and chromatin remodeling in lung inflammation. Biochem. Pharmacol. 64:935-942.
67. Guarente, L. 2000. Sir2 links chromatin silencing, metabolism, and aging. Genes Dev. 14:1021-1026.
68. Luo, J., et al. 2001. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 107:137-148.
69. Clement, M,V., and Pervaiz, S. 1999. Reactive oxygen intermediates regulate cellular response to apoptotic stimuli: an hypothesis. Free Radic. Res. 30:247-252.
70. Chan, P.H. 2001. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21:2-14.
71. Droge, W. 2002. Free radicals in the physiological control of cell function. Physiol. Rev. 82:47-95.
72. Maulik, N., and Das, D.K. 2002. Redox signaling in vascular angiogenesis. Free Radic. Biol. Med. 33:1047-1060.
73. Huang, R.P., Wu, J.X., Fan, Y., and Adamson, E.D. 1996. UV activates growth factor receptors via reactive oxygen intermediates. J. Cell Biol. 133:211-220.
74. Martindale, J. L., and Holbrook, N.J. 2002. Cellular response to oxidative stress: signaling for suicide and survival. J. Cell. Physiol. 192:1-15.
75. Ravid, T., Sweeney, C., Gee, P., Carraway, K.L., 3rd, and Goldkorn, T. 2002. Epidermal growth factor receptor activation under oxidative stress fails to promote c-Cbl mediated down-regulation. J. Biol. Chem. 277:31214-31219.
76. Nakamura, T., and Sakamoto, K. 2001. Reactive oxygen species up-regulates cyclooxygenase-2, p53, and Bax mRNA expression in bovine luteal cells. Biochem. Biopbys. Res. Commun. 284:203-210.
77. Han, J.A., et al. 2002. P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBOJ. 21:5635-5644.
78. Shirvan, A., et al. 1998. Expression of cell cycle-related genes during neuronal apoptosis: is there a distinct pattern? Neurochem. Res. 23:767-777.
79. Trotter, L., et al. 2002. Mitogen-activated protein kinase kinase 7 is activated during low potassium-induced apoptosis in rat cerebellar granule neurons. Neurosci. Lett. 320:29-32.
80. Crossthwaite, A.J., Hasan, S., and Williams, R.J. 2002. Hydrogen peroxide-mediated phosphorylation of ERK1/2, Akt/PKB and JNK in cortical neurones: dependence on Ca(2+) and PI3-kinase. J. Neurocbem. 80:24-35.
81. Li, N., and Karin, M. 1999. Is NF-kappaB the sensor of oxidative stress? FASEB J. 13:1137-1143.
82. Mattson, M.P., and Camandola, S. 2001. NF-κB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107:247-254.
83. Birecree, E., Whetsell, W.O., Jr., Stoscheck, C., King, L.E., Jr., and Nanney, L.B. 1988. Immunoreactive epidermal growth factor receptors in neuritic plaques from patients with Alzheimer's disease. J. Neuropathol. Exp. Neurol. 47:549-560.
84. Zhu, X., et al. 2000. Activation ofoncogenic pathways in degenerating neurons in Alzheimer disease. Int. J. Dev. Neurosci. 18:433-437.
85. Zhu, X., et al. 2000. Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease. J. Neuropathol. Exp. Neurol. 59:880-888.
86. Atzori, C., et al. 2001. Activation of the JNK/p38 pathway occurs in diseases characterized by tau protein pathology and is related to tau phosphorylation but not to apoptosis. J. Neuropathol. Exp. Neurol. 60:1190-1197.